Charles D Burnette Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10 Hospital Dr, Bridgton, ME 04009 Phone: 207-647-6000 Fax: 207-647-6065 |
News Archive
Promega Corporation today announced it has entered into a global collaboration with Merck, to develop Promega's microsatellite instability technology.
NasVax announces the success of a Phase 2a clinical trial of a new oral immunotherapy for non-alcoholic steatohepatitis (NASH), an inflammatory disease associated with fatty liver disease and the metabolic syndrome.
Heart failure patients discharged from the hospital with a reduced level of a common hormone produced by the heart had significantly lower rates of readmission and lower death rates, according to a new study conducted by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City.
In a new study researchers have found that girls who survive childhood cancer are more likely to experience an early menopause when they mature than other women.
Intercell AG today announced results from a Phase II clinical trial involving the company's investigational nosocomial vaccine candidate (IC43) against infections with the bacterium Pseudomonas aeruginosa, a leading cause of hospital-acquired infections with increasing antibiotic resistance and hence a very high unmet medical need.
› Verified 6 days ago